Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Moodys
US Department of Justice
Covington
Federal Trade Commission
Colorcon

Generated: April 18, 2019

DrugPatentWatch Database Preview

Nextwave Company Profile

« Back to Dashboard

What is the competitive landscape for NEXTWAVE, and what generic alternatives to NEXTWAVE drugs are available?

NEXTWAVE has two approved drugs.

There are twelve US patents protecting NEXTWAVE drugs.

There are thirty-one patent family members on NEXTWAVE drugs in fourteen countries.

Summary for Nextwave
International Patents:31
US Patents:12
Tradenames:2
Ingredients:1
NDAs:2

Drugs and US Patents for Nextwave

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nextwave QUILLIVANT XR methylphenidate hydrochloride FOR SUSPENSION, EXTENDED RELEASE;ORAL 202100-001 Sep 27, 2012 RX Yes Yes 8,956,649 ➤ Sign Up Y ➤ Sign Up
Nextwave Pharms QUILLICHEW ER methylphenidate hydrochloride TABLET, EXTENDED RELEASE, CHEWABLE;ORAL 207960-001 Dec 4, 2015 RX Yes No 9,295,642 ➤ Sign Up Y ➤ Sign Up
Nextwave Pharms QUILLICHEW ER methylphenidate hydrochloride TABLET, EXTENDED RELEASE, CHEWABLE;ORAL 207960-003 Dec 4, 2015 RX Yes Yes 9,545,399 ➤ Sign Up Y ➤ Sign Up
Nextwave Pharms QUILLICHEW ER methylphenidate hydrochloride TABLET, EXTENDED RELEASE, CHEWABLE;ORAL 207960-003 Dec 4, 2015 RX Yes Yes 8,287,903 ➤ Sign Up Y ➤ Sign Up
Nextwave Pharms QUILLICHEW ER methylphenidate hydrochloride TABLET, EXTENDED RELEASE, CHEWABLE;ORAL 207960-003 Dec 4, 2015 RX Yes Yes 9,844,544 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for NEXTWAVE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Oral Suspension 5 mg/mL ➤ Subscribe 2013-08-02
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Baxter
Johnson and Johnson
Medtronic
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.